Antisomnogenic cytokines, quality of life, and chronic rhinosinusitis: A pilot study

Laryngoscope

Volumn 124, Issue 4, 2014, Pages

  Alt, Jeremiah A ^a   Sautter, Nathan B ^a   Mace, Jess C ^a   Detwiller, Kara Y ^a   Smith, Timothy L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

inflammation mediators; quality of life; rhinology; Sinusitis; sleep

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA;

ADULT; CHRONIC RHINOSINUSITIS; CLINICAL ARTICLE; CONFERENCE PAPER; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; ILLNESS BEHAVIOR; MALE; MIDDLE AGED; PILOT STUDY; PITTSBURGH SLEEP QUALITY INDEX; PRIORITY JOURNAL; QUALITY OF LIFE; SLEEP DISORDER; SLEEP QUALITY; SLEEP TIME; YOUNG ADULT;

INFLAMMATION MEDIATORS; QUALITY OF LIFE; RHINOLOGY; SINUSITIS; SLEEP;

ADULT; CHRONIC DISEASE; CYTOKINES; DNA; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RESPIRATORY MUCOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHINITIS; SEVERITY OF ILLNESS INDEX; SINUSITIS; SLEEP; SLEEP DISORDERS; YOUNG ADULT;

EID: 84896545684     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24412     Document Type: Conference Paper

References (65)

1. Rudmik L, Smith TL,. Quality of life in patients with chronic rhinosinusitis. Curr Allergy Asthma Rep 2011; 11: 247-252.
2. Kelley KW, Bluthe RM, Dantzer R, et al. Cytokine-induced sickness behavior. Brain Behav Immun 2003; 17 (suppl 1): S112-S118.
3. Alt JA, Smith TL, Mace JC, Soler ZM,. Sleep quality and disease severity in patients with chronic rhinosinusitis [published online ahead of print August 5, 2013]. Laryngoscope. doi: 10.1002/lary.24040.
4. Krueger JM, Obal F Jr, Fang J,. Why we sleep: a theoretical view of sleep function. Sleep Med Rev 1999; 3: 119-129.
5. Krueger JM,. The role of cytokines in sleep regulation. Curr Pharm Des 2008; 14: 3408-3416.
6. Opp MR, Krueger JM,. Interleukin-1 is involved in responses to sleep deprivation in the rabbit. Brain Res 1994; 639: 57-65.
7. Opp MR, Obal F Jr, Krueger JM,. Interleukin 1 alters rat sleep: temporal and dose-related effects. Am J Physiol 1991; 260: R52-R58.
8. Fang J, Wang Y, Krueger JM,. Effects of interleukin-1 beta on sleep are mediated by the type I receptor. Am J Physiol 1998; 274: R655-R660.
9. Susic V, Totic S,. "Recovery" function of sleep: effects of purified human interleukin-1 on the sleep and febrile response of cats. Metab Brain Dis 1989; 4: 73-80.
10. Deleuran B, Iversen L, Deleuran M, et al. Interleukin 13 suppresses cytokine production and stimulates the production of 15-HETE in PBMC. A comparison between IL-4 and IL-13. Cytokine 1995; 7: 319-324.
11. Muzio M, Sironi M, Polentarutti N, Mantovani A, Colotta F,. Induction by transforming growth factor-beta 1 of the interleukin-1 receptor antagonist and of its intracellular form in human polymorphonuclear cells. Eur J Immunol 1994; 24: 3194-3198.
12. Suzumura A, Sawada M, Yamamoto H, Marunouchi T,. Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro. J Immunol 1993; 151: 2150-2158.
13. Kou W, Hu GH, Yao HB, et al. Regulation of transforming growth factor-beta1 activation and expression in the tissue remodeling involved in chronic rhinosinusitis. ORL J Otorhinolaryngol Relat Spec 2012; 74: 172-178.
14. al Ghamdi K, Ghaffar O, Small P, Frenkiel S, Hamid Q,. IL-4 and IL-13 expression in chronic sinusitis: relationship with cellular infiltrate and effect of topical corticosteroid treatment. J Otolaryngol 1997; 26: 160-166.
15. Kushikata T, Fang J, Krueger JM,. Interleukin-10 inhibits spontaneous sleep in rabbits. J Interferon Cytokine Res 1999; 19: 1025-1030.
16. Kushikata T, Fang J, Wang Y, Krueger JM,. Interleukin-4 inhibits spontaneous sleep in rabbits. Am J Physiol 1998; 275: R1185-R1191.
17. Kubota T, Fang J, Kushikata T, Krueger JM,. Interleukin-13 and transforming growth factor-beta1 inhibit spontaneous sleep in rabbits. Am J Physiol Regul Integr Comp Physiol 2000; 279: R786-R792.
18. Krouse HJ, Davis JE, Krouse JH,. Immune mediators in allergic rhinitis and sleep. Otolaryngol Head Neck Surg 2002; 126: 607-613.
19. Rosenfeld RM, Andes D, Bhattacharyya N, et al. Clinical practice guideline. Otolaryngol Head Neck Surg 2007; 137: S1-S31.
20. Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ,. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213.
21. Benninger MS, Senior BA,. The development of the Rhinosinusitis Disability Index. Arch Otolaryngol Head Neck Surg 1997; 123: 1175-1179.
22. Piccirillo JF, Merritt MG Jr, Richards ML,. Psychometric and clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20). Otolaryngol Head Neck Surg 2002; 126: 41-47.
23. Lund VJ, Mackay IS,. Staging in rhinosinusitis. Rhinology 1993; 31: 183-184.
24. Lund VJ, Kennedy DW,. Staging for rhinosinusitis. Otolaryngol Head Neck Surg 1997; 117: 35-40.
25. Doty R,. The Smell Identification Test Administration Manual. Haddon Heights, NJ: Sensonics, Inc.; 2001. http://www.cdc.gov/alcohol/fact-sheets/ alcohol-use.htm. Accessed June, 2013.
26. Center for Disease Control and Prevention. Fact sheets-alcohol use and health. Available at: http://www.cdc.gov/alcohol/fact-sheets/alcohol-use.htm.
27. Omachi TA,. Measures of sleep in rheumatologic diseases: Epworth Sleepiness Scale (ESS), Functional Outcome of Sleep Questionnaire (FOSQ), Insomnia Severity Index (ISI), and Pittsburgh Sleep Quality Index (PSQI). Arthritis Care Res (Hoboken) 2012; 63 (Suppl 11): S287-S296.
28. Jankelowitz L, Reid KJ, Wolfe L, Cullina J, Zee PC, Jain M,. Cystic fibrosis patients have poor sleep quality despite normal sleep latency and efficiency. Chest 2005; 127: 1593-1599.
29. Batmaz I, Sariyildiz MA, Dilek B, Bez Y, Karakoc M, Cevik R,. Sleep quality and associated factors in ankylosing spondylitis: relationship with disease parameters, psychological status and quality of life. Rheumatol Int 2013; 33: 1039-1045.
30. Wells GA, Li T, Kirwan JR, et al. Assessing quality of sleep in patients with rheumatoid arthritis. J Rheumatol 2009; 36: 2077-2086.
31. Obal F Jr, Krueger JM,. Biochemical regulation of non-rapid-eye-movement sleep. Front Biosci 2003; 8: d520-d550.
32. Colotta F, Re F, Muzio M, et al. Interleukin-13 induces expression and release of interleukin-1 decoy receptor in human polymorphonuclear cells. J Biol Chem 1994; 269: 12403-12406.
33. Re F, Muzio M, De Rossi M, et al. The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor. J Exp Med 1994; 179: 739-743.
34. Cosentino G, Soprana E, Thienes CP, Siccardi AG, Viale G, Vercelli D,. IL-13 down-regulates CD14 expression and TNF-alpha secretion in normal human monocytes. J Immunol 1995; 155: 3145-3151.
35. Quan N, Banks WA,. Brain-immune communication pathways. Brain Behav Immun 2007; 21: 727-735.
36. Turnbull AV, Rivier CL,. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 1999; 79: 1-71.
37. Watkins LR, Maier SF, Goehler LE,. Cytokine-to-brain communication: a review and analysis of alternative mechanisms. Life Sci 1995; 57: 1011-1026.
38. Campisi J, Hansen MK, O'Connor KA, et al. Circulating cytokines and endotoxin are not necessary for the activation of the sickness or corticosterone response produced by peripheral E. coli challenge. J Appl Physiol 2003; 95: 1873-1882.
39. Hansen MK, O'Connor KA, Goehler LE, Watkins LR, Maier SF,. The contribution of the vagus nerve in interleukin-1beta-induced fever is dependent on dose. Am J Physiol Regul Integr Comp Physiol 2001; 280: R929-R934.
40. Niijima A,. The afferent discharges from sensors for interleukin 1 beta in the hepatoportal system in the anesthetized rat. J Auton Nerv Syst 1996; 61: 287-291.
41. Dubois CM, Ruscetti FW, Keller JR, et al. In vivo interleukin-1 (IL-1) administration indirectly promotes type II IL-1 receptor expression on hematopoietic bone marrow cells: novel mechanism for the hematopoietic effects of IL-1. Blood 1991; 78: 2841-2847.
42. Dubois CM, Ruscetti FW, Palaszynski EW, Falk LA, Oppenheim JJ, Keller JR,. Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action. J Exp Med 1990; 172: 737-744.
43. Redini F, Mauviel A, Pronost S, Loyau G, Pujol JP,. Transforming growth factor beta exerts opposite effects from interleukin-1 beta on cultured rabbit articular chondrocytes through reduction of interleukin-1 receptor expression. Arthritis Rheum 1993; 36: 44-50.
44. Bolger WE, Joshi AS, Spear S, Nelson M, Govindaraj K,. Gene expression analysis in sinonasal polyposis before and after oral corticosteroids: a preliminary investigation. Otolaryngol Head Neck Surg 2007; 137: 27-33.
45. Lennard CM, Mann EA, Sun LL, Chang AS, Bolger WE,. Interleukin-1 beta, interleukin-5, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in chronic sinusitis: response to systemic corticosteroids. Am J Rhinol 2000; 14: 367-373.
46. Mullol J, Xaubet A, Lopez E, Roca-Ferrer J, Picado C,. Comparative study of the effects of different glucocorticosteroids on eosinophil survival primed by cultured epithelial cell supernatants obtained from nasal mucosa and nasal polyps. Thorax 1995; 50: 270-274.
47. Opp MR, Postlethwaite AE, Seyer JM, Krueger JM,. Interleukin 1 receptor antagonist blocks somnogenic and pyrogenic responses to an interleukin 1 fragment. Proc Natl Acad Sci U S A 1992; 89: 3726-3730.
48. Bauer J, Hohagen F, Ebert T, et al. Interleukin-6 serum levels in healthy persons correspond to the sleep-wake cycle. Clin Investig 1994; 72: 315.
49. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab 1999; 84: 2603-2607.
50. Hogan D, Morrow JD, Smith EM, Opp MR,. Interleukin-6 alters sleep of rats. J Neuroimmunol 2003; 137: 59-66.
51. Ghaffar O, Lavigne F, Kamil A, Renzi P, Hamid Q,. Interleukin-6 expression in chronic sinusitis: colocalization of gene transcripts to eosinophils, macrophages, T lymphocytes, and mast cells. Otolaryngol Head Neck Surg 1998; 118: 504-511.
52. Opp MR, Smith EM, Hughes TK Jr,. Interleukin-10 (cytokine synthesis inhibitory factor) acts in the central nervous system of rats to reduce sleep. J Neuroimmunol 1995; 60: 165-168.
53. Toth LA, Opp MR,. Cytokine- and microbially induced sleep responses of interleukin-10 deficient mice. Am J Physiol Regul Integr Comp Physiol 2001; 280: R1806-R1814.
54. Jyonouchi H, Sun S, Le H, Rimell, FL,. Evidence of dysregulated cytokine production by sinus lavage and peripheral blood mononuclear cells in patients with treatment-resistant chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg 2001; 127: 1488-1494.
55. Reh DD, Ramanathan M Jr, Sultan B, Wang Y, May L, Lane AP,. The role of hepatocyte growth factor/c-Met in chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy 2010; 24: 266-270.
56. Bohnet SG, Traynor TR, Majde JA, Kacsoh B, Krueger JM,. Mice deficient in the interferon type I receptor have reduced REM sleep and altered hypothalamic hypocretin, prolactin and 2′,5′-oligoadenylate synthetase expression. Brain Res 2004; 1027: 117-125.
57. Kubota T, Majde JA, Brown RA, Krueger JM,. Tumor necrosis factor receptor fragment attenuates interferon-gamma-induced non-REM sleep in rabbits. J Neuroimmunol 2001; 119: 192-198.
58. Tashiro M, Mochizuki H, Iwabuchi K, et al. Roles of histamine in regulation of arousal and cognition: functional neuroimaging of histamine H1 receptors in human brain. Life Sci 2002; 72: 409-414.
59. Wisor JP, Clegern WC, Schmidt MA,. Toll-like receptor 4 is a regulator of monocyte and electroencephalographic responses to sleep loss. Sleep 2011; 34: 1335-1345.
60. Sartorius T, Lutz SZ, Hoene M, et al. Toll-like receptors 2 and 4 impair insulin-mediated brain activity by interleukin-6 and osteopontin and alter sleep architecture. FASEB J 2012; 26: 1799-1809.
61. Lane AP, Truong-Tran QA, Myers A, Bickel C, Schleimer RP,. Serum amyloid A, properdin, complement 3, and toll-like receptors are expressed locally in human sinonasal tissue. Am J Rhinol 2006; 20: 117-123.
62. Sri Kantha S, Matsumura H, Kubo E, et al. Effects of prostaglandin D2, lipoxins and leukotrienes on sleep and brain temperature of rats. Prostaglandins Leukot Essent Fatty Acids 1994; 51: 87-93.
63. Hayaishi O, Urade Y,. Prostaglandin D2 in sleep-wake regulation: recent progress and perspectives. Neuroscientist 2002; 8: 12-15.
64. Urade Y, Hayaishi O,. Prostaglandin D2 and sleep/wake regulation. Sleep Med Rev 2011; 15: 411-418.
65. Krueger JM, Kapas L, Opp MR, Obal F Jr,. Prostaglandins E2 and D2 have little effect on rabbit sleep. Physiol Behav 1992; 51: 481-485.